Trial · NCT03737994
Adverse events540
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 540
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Lorlatinib (Mutations) | 0 | 1 | |
| other | Anemia | Blood and lymphatic system disorders | Lorlatinib (no Mutations) | 1 | 2 | |
| other | Anemia | Blood and lymphatic system disorders | LDK378 (Ceritinib) | 0 | 1 | |
| other | Anemia | Blood and lymphatic system disorders | Brigatinib (Mutations) | 0 | 1 | |
| other | Anemia | Blood and lymphatic system disorders | Brigatinib (no Mutations) | 1 | 1 | |
| other | Anemia | Blood and lymphatic system disorders | Ensartinib | 1 | 3 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Lorlatinib (Mutations) | 1 | 1 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Lorlatinib (no Mutations) | 0 | 2 | |
| other | Eosinophilia | Blood and lymphatic system disorders | LDK378 (Ceritinib) | 0 | 1 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Brigatinib (Mutations) | 0 | 1 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Brigatinib (no Mutations) | 0 | 1 | |
| other | Eosinophilia | Blood and lymphatic system disorders | Ensartinib | 1 | 3 | |
| other | Cardiac disorders - Other | Cardiac disorders | Lorlatinib (Mutations) | 0 | 1 | |
| other | Cardiac disorders - Other | Cardiac disorders | Lorlatinib (no Mutations) | 0 | 2 | |
| other | Cardiac disorders - Other | Cardiac disorders | LDK378 (Ceritinib) | 1 | 1 | |
| other | Cardiac disorders - Other | Cardiac disorders | Brigatinib (Mutations) | 0 | 1 | |
| other | Cardiac disorders - Other | Cardiac disorders | Brigatinib (no Mutations) | 0 | 1 | |
| other | Cardiac disorders - Other | Cardiac disorders | Ensartinib | 0 | 3 | |
| other | Pericardial effusion | Cardiac disorders | Lorlatinib (Mutations) | 0 | 1 | |
| other | Pericardial effusion | Cardiac disorders | Lorlatinib (no Mutations) | 1 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03737994/events